Norges Bank Axcella Health Inc. Transaction History

Norges Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$3.08 - $5.9 $95,464 - $182,870	-30,995 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$5.25 - $9.26 $162,723 - $287,013	30,995 New	30,995 $175,000
Q3 2019 Nov 08, 2019	SELL	$5.25 - $9.26 $262,500 - $463,000	-50,000 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$8.51 - $14.95 $425,500 - $747,500	50,000 New	50,000 $466,000

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.